Literature DB >> 17010786

Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents.

Shpend Elezi1, Alban Dibra, Julinda Mehilli, Jürgen Pache, Rainer Wessely, Albert Schömig, Adnan Kastrati.   

Abstract

OBJECTIVES: This study sought to investigate the influence of vessel size on the outcomes of patients after drug-eluting stent (DES) implantation.
BACKGROUND: There are no dedicated studies on the influence of vessel size on the outcomes of patients treated with different DES.
METHODS: The study population was composed of 2,058 consecutive patients who received sirolimus-eluting stents (SES) or paclitaxel-eluting stents (PES). Patients were grouped into tertiles according to vessel size (<2.41 mm in the lower tertile, 2.41 to 2.84 mm in the middle tertile, and >2.84 mm in the upper tertile). The primary end point was target lesion revascularization (TLR). Secondary end points were binary angiographic restenosis and the composite of death or myocardial infarction.
RESULTS: Vessel size did not influence the composite end point of death and myocardial infarction. The TLR rates were higher among patients in the lower tertile (12.1%) as compared with the middle (8.4%) and upper (8.0%) tertiles (p = 0.02). In a multivariate analysis, vessel size emerged an independent predictor of TLR (p = 0.009). The model showed also a significant interaction between DES type and vessel size regarding TLR (p = 0.008). There was a significant difference in TLR rates among patients treated with SESs (8.6%) and PESs (16.4%) in the lower tertile (p = 0.002), but not in the middle and upper tertiles.
CONCLUSIONS: The influence of vessel size on restenosis is related to the specific DES used, with SESs providing better outcomes than PESs in small but not in large coronary vessels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010786     DOI: 10.1016/j.jacc.2006.05.068

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  18 in total

1.  Cobalt-chromium stents in long lesions of large vessels: clinical and angiographic results.

Authors:  Iñigo Lozano; Carlos Cuellas; Pablo Avanzas; Armando Pérez de Prado; Concepción Suárez; Juan Rondan; Daehyun Lee; Jesus M de la Hera; Felipe Fernández; César Morís
Journal:  Tex Heart Inst J       Date:  2011

2.  Clinical outcomes with Biolimus (A9)™ eluting stent, 'BioMatrix' in diabetic patients--interim results from multicenter post market surveillance registry in India.

Authors:  Ashok Seth; Shirish Hiremath; Sameer Dani; Sunil Kapoor; R K Jain; Rajpal Abhaichand; Shailendra Trivedi; Upendra Kaul; Aruna Patil; Bhushan Khemnar; Hrishikesh Rangnekar
Journal:  Indian Heart J       Date:  2013-09-21

3.  Treatment of small coronary arteries with a paclitaxel-coated balloon catheter.

Authors:  Martin Unverdorben; Franz X Kleber; Hubertus Heuer; Hans-Reiner Figulla; Christian Vallbracht; Matthias Leschke; Bodo Cremers; Stefan Hardt; Michael Buerke; Hanns Ackermann; Michael Boxberger; Ralf Degenhardt; Bruno Scheller
Journal:  Clin Res Cardiol       Date:  2010-01-06       Impact factor: 5.460

Review 4.  New drug-eluting stent concepts.

Authors:  Rainer Wessely
Journal:  Nat Rev Cardiol       Date:  2010-03-02       Impact factor: 32.419

5.  Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT Trial.

Authors:  Rosaly A Buiten; Eline H Ploumen; Paolo Zocca; Carine J M Doggen; Liefke C van der Heijden; Marlies M Kok; Peter W Danse; Carl E Schotborgh; Martijn Scholte; Frits H A F de Man; Gerard C M Linssen; Clemens von Birgelen
Journal:  JAMA Cardiol       Date:  2019-07-01       Impact factor: 14.676

6.  Short- and long-term benefits of drug-eluting stents compared to bare metal stents even in treatment for large coronary arteries.

Authors:  Taiji Yoshida; Kenji Sakata; Yutaka Nitta; Tomio Taguchi; Bunji Kaku; Shoji Katsuda; Masaya Shimojima; Tadatsugu Gamou; Takuya Nakahashi; Tetsuo Konno; Masa-Aki Kawashiri; Masakazu Yamagishi; Kenshi Hayashi
Journal:  Heart Vessels       Date:  2015-03-11       Impact factor: 2.037

7.  Ultrathin (60 μm), ultralong (≥40 mm) sirolimus-eluting stent: study of clinical and safety profiles among real-world patients.

Authors:  Santosh Kumar Sinha; Puneet Aggarwal; Umeshwar Pandey; Mahmodullah Razi; Awdesh Kumar; Vinay Krishna
Journal:  Anatol J Cardiol       Date:  2021-02       Impact factor: 1.596

Review 8.  Small vessel coronary artery disease: How small can we go with myocardial revascularization?

Authors:  Maciej T Wybraniec; Paweł Bańka; Tomasz Bochenek; Tomasz Roleder; Katarzyna Mizia-Stec
Journal:  Cardiol J       Date:  2020-09-28       Impact factor: 2.737

9.  Predicting target vessel revascularization in older patients undergoing percutaneous coronary intervention in the drug-eluting stent era.

Authors:  Connie N Hess; Sunil V Rao; David Dai; Megan L Neely; Robert N Piana; John C Messenger; Eric D Peterson
Journal:  Am Heart J       Date:  2014-01-04       Impact factor: 4.749

10.  Outcomes of patients treated with a biodegradable-polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stents after rotational atherectomy.

Authors:  Nader Mankerious; Rayyan Hemetsberger; Hussein Traboulsi; Ralph Toelg; Mohamed Abdel-Wahab; Gert Richardt; Abdelhakim Allali
Journal:  Clin Res Cardiol       Date:  2021-04-16       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.